Bio SB performs R&D, production, distribution of antibodies and detection systems for immunohistochemistry (IHC), including environmentally friendly ancillaries, unique IVD validated antibodies, detection systems and equipment. Our portfolio includes products for immunohistochemistry (IHC) immunocytochemistry (ICC), Immunofluorescence (IF), chromogenic in situ hybridization (CISH) and fluorescent in situ hybridization (FISH) technologies that meet the highest international standards for applications in molecular pathology, cancer research, microbiology, immunology and genetics. Bio SB manufactures and develops products in accordance with FDA QSR 21 CFR Part 820 cGMP, CE IVD and ISO13485:2016 certifications.
|October, 2021||FedPatMex virtual Convention. Dr Heras to present a talk about Development of SARS-CoV-2 IHC to assess the Pathogenesis, Cytokine Storm Syndrome and Coagulopathy||Webinar|
|September, 2021||NSH Mohs IHC workshop sponsored by Bio SB & conducted by Jonathan Hetts of Oregon State||Workshop|
|April 29th – May 2nd, 2020||52nd Annual Convention of the Mexican Association of Pathology, Guadalajara, Mexico||Website|
|April 24th – 29th, 2020||AACR 2020 Annual Meeting, San Diego, California||Website|
|April 23rd – 26th, 2020||American College of Mohs Surgery 2020 Annual Meeting, Nashville, Tennessee||Website|
|February 29th – March 5th, 2020||USCAP 2020 Annual Meeting, Los Angeles, California||Website|